Series B funding round for Fusion Pharmaceuticals raising $110M in March 2019
Series B funding round for Fusion Pharmaceuticals raising $110M in March 2019
| Investor | Firm Type | Partner |
|---|
OrbiMedLEAD | Venture Capital | — |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Heather Preston |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Fusion Pharmaceuticals raised $110M in a Series B round.
The round was announced on 03/01/19.
The round was led by OrbiMed, Deepak Khuntia.